Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI108825

Sites and Mechanisms of Localization of Technetium-99m Phosphorus Radiopharmaceuticals in Acute Myocardial Infarcts and other Tissues

L. Maximilian Buja, Andrew J. Tofe, Padmakar V. Kulkarni, Amal Mukherjee, Robert W. Parkey, Marion D. Francis, Frederick J. Bonte, and James T. Willerson

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Buja, L. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Tofe, A. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Kulkarni, P. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Mukherjee, A. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Parkey, R. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Francis, M. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Bonte, F. in: PubMed | Google Scholar

Department of Pathology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Radiology, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

Department of Internal Medicine, Southwestern Medical School, The University of Texas Health Science Center at Dallas, Dallas, Texas 75235

The Miami Valley Laboratories, The Procter and Gamble Company, Cincinnati, Ohio 45239

Find articles by Willerson, J. in: PubMed | Google Scholar

Published September 1, 1977 - More info

Published in Volume 60, Issue 3 on September 1, 1977
J Clin Invest. 1977;60(3):724–740. https://doi.org/10.1172/JCI108825.
© 1977 The American Society for Clinical Investigation
Published September 1, 1977 - Version history
View PDF
Abstract

This study was performed to elucidate the localization at the cellular level of technetium-99m phosphorus (99mTc-P) radiopharmaceuticals in acute myocardial infarcts and the mechanisms responsible for 99mTc-P uptake in acute myocardial infarcts and other tissues. In 20 dogs with proximal left anterior descending coronary arterial ligation for 1-3 days, elevated calcium levels were measured at all sites of increased 99mTc-P uptake (acute myocardial infarcts, necrotic thoracotomy muscle, lactating breast, and normal bone); however, a consistent linear relationship between 99mTc-P and calcium levels was not observed. A strong correlation (r = 0.95 and 0.99, n = 2 dogs) was demonstrated between levels of 3H-diphosphonate and 99mTc-P in infarcted myocardium. Autoradiographic studies with 3H-diphosphonate revealed extensive labeling in the infarct periphery which contained necrotic muscle cells with features of severe calcium overloading, including widespread hypercontraction as well as more selective formation of mitochondrial calcific deposits. Autoradiography also demonstrated labeling of a small population of damaged border zone muscle cells which exhibited prominent accumulation of lipid droplets and focal, early mitochondrial calcification. Cell fractionation studies revealed major localization of both 99mTc-P and calcium in the soluble supernate and membrane-debris fractions of infarcted myocardium and less than 2% of total 99mTc-P and calcium in the mitochondrial fractions; however, electron microscopic examination showed that mitochondria with calcific deposits were not preserved in the mitochondrial fractions. In vitro studies evaluating the role of serum protein binding on tissue uptake of 99mTc-P agents demonstrated that, in spite of significant complexing with serum proteins, serum 99mTc-P activity retained the ability to adsorp to calcium hydroxyapatite and amorphous calcium phosphate. In vivo studies showed that concentration of human serum albumin (labeled with iodine-131) in infarcted myocardium reached a maximum of only 3.8 times normal after a circulation time of 96 h, whereas 99mTc-P uptake was at least 10 times normal after a circulation time as short as 1 h. It is concluded that: (a) 99mTc-P uptake in acutely infarcted myocardium, and possibly other types of soft tissue damage, is limited to necrotic and severely injured cells; (b) concentration of 99mTc-P results from selective adsorption of 99mTc-P with various forms of tissue calcium stores, including amorphous calcium phosphate, crystalline hydroxyapatite, and calcium complexed with myofibrils and other macromolecules, possibly supplemented by calcium-independent complexing with organic macromolecules; and (c) lack of a linear relationship between 99mTc-P and tissue calcium levels mainly results from local differences in composition and physicochemical properties of tissue calcium stores and from local variations in levels of blood flow for delivery of 99mTc-P agents.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 724
page 724
icon of scanned page 725
page 725
icon of scanned page 726
page 726
icon of scanned page 727
page 727
icon of scanned page 728
page 728
icon of scanned page 729
page 729
icon of scanned page 730
page 730
icon of scanned page 731
page 731
icon of scanned page 732
page 732
icon of scanned page 733
page 733
icon of scanned page 734
page 734
icon of scanned page 735
page 735
icon of scanned page 736
page 736
icon of scanned page 737
page 737
icon of scanned page 738
page 738
icon of scanned page 739
page 739
icon of scanned page 740
page 740
Version history
  • Version 1 (September 1, 1977): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts